Ars Prescription drugs’ chief enterprise officer sells $2.04 million in inventory

These transactions adopted the train of inventory choices, the place Chakma acquired a complete of 144,640 shares at an train worth of $0.84 per share. Publish-transaction, Chakma retains a direct possession of 136,380 shares in ARS Prescription drugs. Need deeper insights into insider buying and selling patterns and 13 extra key metrics? Uncover extra with an InvestingPro subscription. Need deeper insights into insider buying and selling patterns and 13 extra key metrics? Uncover extra with an InvestingPro subscription.

These transactions adopted the train of inventory choices, the place Chakma acquired a complete of 144,640 shares at an train worth of $0.84 per share. Publish-transaction, Chakma retains a direct possession of 136,380 shares in ARS Prescription drugs.

In different latest information, ARS Prescription drugs has entered a world settlement with ALK-Abelló A/S for its epinephrine nasal spray, EURneffy. The deal consists of an upfront cost of $145 million to ARS Prescription drugs, with potential extra milestones that might whole as much as $320 million. The corporate additionally secured a provide settlement with Nuova Ompi S.r.l. for glass microvials for his or her emergency treatment, neffy®, and up to date its manufacturing settlement with Renaissance Lakewood, LLC.

ARS Prescription drugs has introduced the provision of neffy®, a needle-free epinephrine remedy for Kind I Allergic Reactions, by prescription throughout america. The corporate has additionally submitted a supplemental New Drug Utility for neffy® 1 mg, a needle-free epinephrine remedy geared toward youngsters. The European Fee has accepted EURneffy, marking a major milestone in allergy remedy.

Analyst agency Cantor Fitzgerald has initiated protection of ARS Prescription drugs with an Chubby ranking. These latest developments spotlight the corporate’s ongoing efforts to increase their product choices and attain within the pharmaceutical business.

This text was generated with the assist of AI and reviewed by an editor. For extra info see our T&C.